Department for Older Adults, GGZinGeest, Osdorpplein 880, 1068 TD, Amsterdam, The Netherlands.
Curr Psychiatry Rep. 2011 Aug;13(4):267-73. doi: 10.1007/s11920-011-0204-4.
Anxiety disorders are a major clinical problem in late life; estimated prevalence rates vary from 6% to 10%, and the disease impact is considerable and equal to that of depression. However, anxiety disorders often remain undetected and untreated in older adults. This discrepancy may be accounted for by a combination of patient variables (eg, a lack of help-seeking behavior and long duration of illness) and variables related to current clinical practice (eg, a lack of knowledge regarding late-life anxiety and ageism). Because anxiety disorders usually have an age at onset earlier in life, patients and mental health professionals may be inclined to attribute the anxiety and avoidance symptoms to personality factors instead of a treatable syndrome. Comorbidity with other psychiatric disorders, such as depressive disorder, may complicate the appropriate diagnosis. Identification may be further obscured because the phenomenology of anxiety disorders in older adults tends to differ from the phenomenology in younger adults. Randomized controlled trials have yielded support for the effectiveness of cognitive-behavioral therapy and serotonergic antidepressants. However, both treatments seem hampered by relatively high dropout rates, and the available data are based primarily on a relatively healthy, well-educated, and "young" older population. The dissemination of knowledge regarding late-life anxiety disorders is vital, as evidence-based treatments are available but are still rarely implemented.
焦虑障碍是老年人中一个主要的临床问题;估计患病率在 6%到 10%之间,疾病的影响相当大,与抑郁症相当。然而,焦虑障碍在老年人中常常未被发现和治疗。这种差异可能是由患者变量(例如,缺乏寻求帮助的行为和疾病持续时间长)和与当前临床实践相关的变量(例如,对老年期焦虑的了解不足和年龄歧视)共同造成的。由于焦虑障碍通常在生命早期发病,患者和精神卫生专业人员可能倾向于将焦虑和回避症状归因于人格因素,而不是可治疗的综合征。与其他精神障碍(如抑郁症)的共病可能使适当的诊断复杂化。识别可能会更加困难,因为老年人的焦虑障碍的表现形式往往与年轻人不同。随机对照试验为认知行为疗法和血清素类抗抑郁药的有效性提供了支持。然而,这两种治疗方法似乎都受到相对较高的辍学率的阻碍,并且现有数据主要基于相对健康、受过良好教育和“年轻”的老年人群。传播关于老年期焦虑障碍的知识至关重要,因为已经有了基于证据的治疗方法,但仍很少实施。